Borrell, S., and S. Gagneux. 2009. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 13(12):1456-1466.

Brooks, S. M., N. L. Lassiter, and E. C. Young. 1973. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. American Review of Respiratory Disease 108(4):799-804.

Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis. BMC Infectious Diseases 9:67.

Coker, R. J. 2004. Review: Multidrug-resistant tuberculosis: Public health challenges. Tropical Medicine and International Health 9(1):25-40.

Deivanayagam, C. N., S. Rajasekaran, R. Venkatesan, A. Mahilmaran, P. R. Ahmed, S. Annadurai, S. Kumar, C. Chandrasekar, N. Ravichandran, and R. Pencillaiah. 2002. Prevalence of acquired MDR-TB and HIV co-infection. Indian Journal of Chest Diseases and Allied Sciences 44(4):237-242.

Dewan, P. K., D. Gupta, B. G. Williams, R. Thakur, D. Bachani, A. Khera, D. F. Wares, S. Sahu, D. C. Reddy, N. Raizada, and L. S. Chauhan. 2010. National estimate of HIV seroprevalence among tuberculosis patients in India. International Journal of Tuberculosis and Lung Disease 14(2):247-249.

Drobac, P. C., J. S. Mukherjee, J. K. Joseph, C. Mitnick, J. J. Furin, H. del Castillo, S. S. Shin, and M. C. Becerra. 2006. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics 117(6):2022-2029.

Drobniewski, F., I. Eltringham, C. Graham, J. G. Magee, E. G. Smith, and B. Watt. 2002. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax 57(9):810-816.

Dye, C., and B. G. Williams. 2010. The population dynamics and control of tuberculosis. Science 328(5980):856-861.

Escombe, A. R., D. A. Moore, R. H. Gilman, W. Pan, M. Navincopa, E. Ticona, C. Martínez, L. Caviedes, P. Sheen, A. Gonzalez, C. J. Noakes, J. S. Friedland, and C. A. Evans. 2008. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Medicine 5(9):e188.

Fairlie, L., N. C. Beylis, G. Reubenson, D. P. Moore, and S. A. Madhi. 2011. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: A cross sectional study. BMC Infectious Diseases 11:28.

Fiegel, J., L. Garcia-Contreras, M. Thomas, J. VerBerkmoes, K. Elbert, A. Hickey, and D. Edwards. 2008. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Pharmaceutical Research 25(4):805-811.

Frieden, T. R., P. I. Fujiwara, R. M. Washko, and M. A. Hamburg. 1995. Tuberculosis in New York City—Turning the tide. New England Journal of Medicine 333(4):229-233.

Gagneux, S., C. D. Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312(5782):1944-1946.

Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575-1580.

Gandhi, N. R., S. Shah, J. R. Andrews, V. Vella, A. P. Moll, M. Scott, D. Weissman, C. Marra, U. G. Lalloo, and G. H. Friedland on behalf of the Tugela Ferry Care and Research (TF CARES) Collaboration. 2010. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. American Journal of Respiratory and Critical Care Medicine 181:80-86.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement